FDA clears Accuray's entire body CyberKnife radiosurgery:
This article was originally published in Clinica
Accuray has received US FDA 510(k) clearance to market its robotic system for providing noninvasive radiosurgical ablation therapy for lesions anywhere in the body where radiation treatment is indicated. The CyberKnife with Dynamic Tracking Software is a stereotactic radiosurgery system that integrates robotics with image-guidance technology to destroy small tumours with large doses of accurately targeted radiation. The CyberKnife was previously cleared by the FDA in 1999 for use in the head and neck above the cervico-thoracic junction, says the Sunnyvale, California firm.